Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Targeting the vulnerability to NAD(+) depletion in B-cell acute lymphoblastic leukemia [PMID: 28904384] Laboratory literature summary: Targeting the vulnerability to NAD(+) depletion in B-cell acute lymphoblastic leukemia
It can reach target tissues and inhibit nicotinamide N-methyltransferase (NNMT) due to its tiny molecular size, which facilitates effective absorption through the digestive system
RELATED: Can you take too much B12
At Licensed Peptides, quality isnt a claim
Concentration matrices, temporal exposure strategies, mechanistic readouts, scaffold design, and long-term remodeling assessments are essential to move from speculative appeal toward validated research relevance
For any licensed injectable medicine, storage conditions and shelf life after reconstitution are defined in the product's SmPC
US$ 25.47
US$ 29.05
US$ 21.79
